AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Other Non-current Liabilities

Long-term obligations not reported separately, such as lease or pension liabilities.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Other Non-current Liabilities · Q3 FY2025 · quarter ended Sep 2025

Other non-current liabilities of €8.11M in Q3 FY2025

Q3 FY2025 other non-current liabilities was €8.11M.

Context

  • Other non-current liabilities amounted to 4.9% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€8.11M— QoQ
Other Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Non-current Liabilities history

Currency unavailable · from the balance sheet

No Other Non-current Liabilities data reported for this period type.

Other Non-current Liabilities vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-current liabilities is compared through growth and share of total assets rather than absolute size.
  • Other non-current liabilities amounts to 4.9% of total assets for AGMB, versus a peer median of 0.0%.
AGMB Competitors
Other Non-current Liabilities for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ACRSAclaris Therapeutics, Inc.Mar 2026$11M USD-64.0%-31.8%5.5%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€8.11M EUR——4.9%
ALMSAlumis Inc. Common StockJun 2026$239K USD-56.9%-89.6%0.0%
ANABAnaptysBio, Inc.Mar 2026$0 USD-100.0%-3.2%0.0%
EQEquillium, Inc.Mar 2026$0 USD——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —-64.0%-31.8%0.0%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.